Accord Biomaterials Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 1

Accord Biomaterials General Information

Description

Provider of catalytic nitric oxide sensor systems. The company's nitric oxide sensor systems utilize proprietary technology and offer catalytic nitric oxide coatings for blood-contacting medical devices, enabling researchers to accurately and reproducibly quantify native bioavailable nitric oxide levels in particular plasma and blood.

Contact Information

Formerly Known As
MC3 Biomaterials
Ownership Status
Out of Business
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 3550 West Liberty
  • Suite 3
  • Ann Arbor, MI 48103
  • United States
+1 (734)
Primary Industry
Biotechnology
Other Industries
Other Healthcare Services
Corporate Office
  • 3550 West Liberty
  • Suite 3
  • Ann Arbor, MI 48103
  • United States
+1 (734)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Accord Biomaterials Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Accelerator/Incubator 01-Jun-2024 Completed Generating Revenue
5. Out of Business 01-Jan-2012 Completed Out of Business
4. Grant 08-Nov-2010 Completed Generating Revenue
3. Later Stage VC 20-Oct-2010 Completed Generating Revenue
2. Later Stage VC (Series A) 01-May-2008 $1M $13.8M Completed Startup
1. Later Stage VC (Series C) 02-Jul-2007 $12.8M $12.8M Completed Startup
To view Accord Biomaterials’s complete valuation and funding history, request access »

Accord Biomaterials Patents

  • 16

    Total Documents Applications and Grants

  • Total Patents Families

  • 5

    Granted

  • Pending

  • Expiring in next 12 mo

Accord Biomaterials Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20090103007-A1 Dielectric barrier discharge lamp, backlight device, and liquid crystal display device Inactive 25-Jan-2006
EP-1968664-B1 Polymer compositions, coatings and devices, and methods of making and using the same Inactive 02-Dec-2005
EP-1968664-A2 Polymer compositions, coatings and devices, and methods of making and using the same Active 02-Dec-2005
US-20090287072-A1 Polymer compositions, coatings and devices, and methods of making and using the same Inactive 02-Dec-2005
CA-2613108-A1 Nitric oxide coatings for medical devices Inactive 30-Jun-2005 A61L29/16
To view Accord Biomaterials’s complete patent history, request access »

Accord Biomaterials Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Innovation Partnerships Venture Capital Minority
To view Accord Biomaterials’s complete investors history, request access »

Ready to get started?

Request a free trial

Accord Biomaterials FAQs

  • When was Accord Biomaterials founded?

    Accord Biomaterials was founded in 2003.

  • Where is Accord Biomaterials headquartered?

    Accord Biomaterials is headquartered in Ann Arbor, MI.

  • What industry is Accord Biomaterials in?

    Accord Biomaterials’s primary industry is Biotechnology.

  • Is Accord Biomaterials a private or public company?

    Accord Biomaterials is a Private company.

  • What is Accord Biomaterials’s current revenue?

    The current revenue for Accord Biomaterials is .

  • How much funding has Accord Biomaterials raised over time?

    Accord Biomaterials has raised $14.9M.

  • Who are Accord Biomaterials’s investors?

    Innovation Partnerships has invested in Accord Biomaterials.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »